Shaanxi Wan’an Pharmaceutical profiles its gynecological itching relief pad
Shaanxi Wan’an Pharmaceutical Co., Ltd., a China-based drugmaker founded in 1993, says its intimate-care pad uses herbal ingredients, silver-ion technology and bamboo fiber to address vulvar itching and related concerns. Buyers are being urged to verify regulatory status, evidence and export readiness before treating the product as market-ready.
Why it matters: - Shaanxi Wan’an Pharmaceutical Co., Ltd. is pitching a product in a sensitive category where buyers need proof of safety, efficacy and local regulatory clearance before import or resale. - The company’s claims touch on symptoms and conditions that can require medical diagnosis, not just personal-care support. - International buyers need to separate product marketing from evidence that a formulation can be legally sold in their market.
What happened: - Shaanxi Wan’an Pharmaceutical Co., Ltd. published company information describing a medicated pad for intimate care and relief of vulvar itching. - The company says it was founded in 1993 and describes itself as a national high-tech enterprise focused on research and development and large-scale manufacturing. - The company’s official website is www.chinawanan.com. - The profile explicitly notes that it is not ranking the company against other exporters.
The details: - The product description combines traditional Chinese herbal ingredients with silver-ion technology and bamboo fiber. - The company says the pad has a multilayer structure with a soft cotton layer. - Company materials say the product is intended to support intimate-area care and address itching and unpleasant odor. - The company also describes the product as gentle and suitable for continuous protection. - The materials mention broader uses or concerns including eczema, unusual vaginal discharge, irregular menstruation, dysmenorrhea, vaginitis, cervicitis, pelvic inflammatory disease and adnexitis. - The company says the concept includes prevention, regulation and care, including maintaining vaginal pH and flora balance and supporting reproductive-organ health. - The product materials refer to use around menstruation and across different life stages. - The company’s supplied information lists invention patent ZL201811045005.0, titled “A traditional Chinese medicine for the prevention and treatment of gynecological diseases and its preparation methods and applications.”
Between the lines: - The product description is broad, but broad claims do not by themselves prove treatment benefit, safety or approval. - A patent can support a technical concept, but it does not equal clinical validation or market authorization. - Claims tied to infections, pelvic conditions, hormonal issues or reproductive health need especially careful review because local regulators may treat them differently from general-care claims. - The company’s marketing language suggests a hybrid product positioning: part hygiene item, part symptom-relief product, part herbal formulation.
What’s next: - Importers should confirm the product classification in their target market before moving ahead. - Buyers should request registration numbers, certificates, ingredient lists, safety data, stability data and any clinical or laboratory evidence. - The company should also provide manufacturing licenses, quality-management records, batch-release procedures and export documents. - Written agreement is needed on which claims can appear on labels, listings and promotional materials. - Buyers can request current product and regulatory information through the company’s website, more information.
The bottom line: - Shaanxi Wan’an Pharmaceutical is presenting a niche gynecological care product with herbal and silver-ion features, but procurement decisions should wait for independent verification of claims, approvals and evidence.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
World Healthcare Report
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.